Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Video interview with Marielle Scherrer-Crosbie, MD, Hospital of the University of Pennsylvania, who explains details of creating a cardio-oncology program, whoi should be involved and the role of cardiac imaging.

Key things to remember when creating a cardio-oncology program

Marielle Scherrer-Crosbie, MD, explains what is needed to create a cardio-oncology program, and the role played by cardiac imagers.

February 12, 2024
Marielle Scherrer-Crosbie, MD, Hospital of the University of Pennsylvania, discusses the latest trends in cardiac strain echo.

Interest in strain echo imaging is rising, but hurdles remain

Marielle Scherrer-Crosbie, MD, told Cardiovascular Business that the current lack of reimbursement for strain echocardiography has been a challenge for care teams. 

February 9, 2024
Video interview with ASNC President Lawrence Phillips, MD, NYU, who is encouraging the modernization of nuclear cardiology labs and expansion into new diagnostic areas.

ASNC president pushes to modernize nuclear cardiology, expand the specialty's reach

ASNC President Lawrence Phillips, MD, wants to see nuclear cardiologists modernize their labs and embrace new strategies for the evaluation of amyloidosis, sarcoidosis and inflammation.

February 7, 2024
transthoracic echocardiogram images from 2024 ASE guidelines

American Society of Echocardiography shares updated expert recommendations on pediatric, neonatal echo

These new guidelines provide a fresh look at topics ASE has not addressed with official society recommendations in many years. 

February 6, 2024
Patient

CT-first strategy the most effective path forward when evaluating stable chest pain

Heart teams have several options when patients present with stable chest pain and require further testing. According to a brand new analysis of nearly 800 patients, CCTA may be the best place to start. 

February 1, 2024
Philips received U.S. Food and Drug Administration (FDA) clearance for a compact transesophageal echocardiography (TEE) ultrasound transducer. The X11-4t Mini 3D TEE transducer was designed to improve image quality when evaluating certain patient populations, including pediatric patients and adults who present with a heightened risk of complications.

FDA clears smaller 3D TEE transducer for imaging children, high-risk adult patients

The newly approved device is much smaller than previous offerings, helping operators capture 3D images during structural heart evaluations. 

January 31, 2024
Jeremy Slivnick, MD, presents at the American Society of Echocardiography (ASE) 2023 meeting on how artificial intelligence (AI) can help make echocardiography better able to detect subtle signs of early cardiac amyloid disease when it is easier to treat with better outcomes. ssistant professor of medicine and an advanced cardiac imager at the University of Chicago.

AI models for cardiac amyloidosis could make a world of difference

Jeremy Slivnick, MD, spoke with Cardiovascular Business about AI's potential to transform how cardiac amyloidosis is diagnosed and treated. 

January 30, 2024
Jamie Bourque, MD, medical director of the nuclear cardiology and stress laboratory, and medical director of the echocardiography lab, at the University of Virginia, discusses a new multimodality consensus statement for imaging cardiac amyloidosis. This area has rapidly expanded over the past couple years now that there are drugs to treat the condition. Examples of nuclear imaging for cardiac amyloidosis.

New ASNC quality metrics will support standardization of imaging for cardiac amyloidosis

Interest in cardiac amyloidosis has been on the rise in recent years. Jamie Bourque, MD, talked to Cardiovascular Business about an upcoming consensus statement focused on using cardiac imaging to evaluate patients for signs of this serious condition. 

January 18, 2024

Around the web

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Using CT to perform coronary artery calcium scoring on symptomatic chest pain patients can deliver significant value, according to a new data published in Radiology

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup